SOURCE: Consulate General of Sweden

March 30, 2006 17:01 ET

World Class Scientists From Sweden and Seattle Present Promising New Research on Type I Diabetes

Predicting & Preventing Childhood Diabetes to Be Discussed at Day-Long Seminar in Seattle

SEATTLE, WA -- (MARKET WIRE) -- March 30, 2006 -- World class scientists from Sweden and Seattle have teamed up to present major research studies at the first Seattle Sweden Diabetes Awareness Day, sponsored by Novo Nordisk, Inc., from 10am-3pm Saturday, April 1 at the Bell Harbor International Conference Center in Seattle. The program presents a unique opportunity for the general public and those affected by Type I diabetes, as well as the scientific community, to ask questions and discuss with leading experts cutting-edge research, new treatments and the promising possibility of prevention. Sweden and Seattle share the commonality of having an extraordinarily high incidence of Type I diabetes. This sobering fact and the high incidence of diabetes nationwide has prompted major research efforts funded by NIH and organizations like the Juvenile Diabetes Research Foundation (JDRF) to determine causes and prevention strategies to avert a worldwide epidemic. "I think we are getting very close to the time when interventions to alter the Type I diabetes process will no longer be considered research, but will be used by practicing clinicians worldwide," says Jerry P. Palmer, M. D., Director of the Diabetes Endocrinology Research Center and Professor of Medicine at the University of Washington.

Seattle Sweden Diabetes Awareness Day is the outgrowth of discussions last year between the Consulate General of Sweden and Åke Lernmark, who heads the TEDDY Study supported by NIH at the University of Washington in Seattle and at University Hospital MAS in Mälmo, Sweden. Lernmark, who is also the official chairman and the architect of Seattle Sweden Diabetes Awareness Day says, "Recent Type I research has resulted in tools that make it possible to predict childhood diabetes, and public awareness and participation in clinical trials will lead to prevention." The program is organized and presented with JDRF, the University of Washington, Children's Hospital and Regional Medical Center, Benaroya Research Institute at Virginia Mason, the Pacific Northwest Research Institute and the Consulate General of Sweden.

"This has been a highly rewarding collaboration with our local Seattle partners and our institutions back home, including Lund University, Karolinska Institute and Linköping University," says Tomas Rosander, Consul General of Sweden in Los Angeles, whose thirteen-state region includes Washington. Sweden is an internationally recognized leader in biotechnology advancements. Seattle Sweden Diabetes Awareness Day is featured as an official program of Beyond Blond 2006, Swedish Lifestyle Month (www.beyondblond.org). In addition to Novo Nordisk, Inc., program sponsors include Swedish companies HemoCue, AB and Diamyd, as well as IKEA, SAS, and locally -based Stellar Holdings International, Inc. For registration and further information, visit jdrfnorthwest.org.

Contact Information

  • Contact:
    Mardi de Veuve-Alexis
    Director of Communications
    Consulate General of Sweden
    (310) 444-3194
    (310) 460-8321 (cell)
    Email Contact

    Kim Davis
    Communications
    Virginia Mason Medical Center
    (206) 583-6451
    Email Contact

    Rich Murphy, PhD
    Director of Community Relations
    Pacific Northwest Research Institute
    (206) 568-1484
    Email Contact

    Katharine Fitzgerald
    Media Relations
    Children's Hospital & Regional Medical Center
    (206) 987-5245
    Email Contact